|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics. 2012.CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics. 2016.CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grady WM and Carethers JM: Genomic and
epigenetic instability in colorectal cancer pathogenesis.
Gastroenterology. 135:1079–1099. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jones PA and Baylin SB: The epigenomics of
cancer. Cell. 128:683–692. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dehan P, Kustermans G, Guenin S, Horion J,
Boniver J and Delvenne P: DNA methylation and cancer diagnosis: New
methods and applications. Expert Rev Mol Diagn. 9:651–657. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shivapurkar N and Gazdar AF: DNA
methylation based biomarkers in non-invasive cancer screening. Curr
Mol Med. 10:123–132. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Urrutia R: KRAB-containing zinc-finger
repressor proteins. Genome Biol. 4:2312003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lupo A, Cesaro E, Montano G, Zurlo D, Izzo
P and Costanzo P: KRAB-zinc finger proteins: A repressor family
displaying multiple biological functions. Curr Genomics.
14:268–278. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huntley S, Baggott DM, Hamilton AT,
Tran-Gyamfi M, Yang S, Kim J, Gordon L, Branscomb E and Stubbs L: A
comprehensive catalog of human KRAB-associated zinc finger genes:
Insights into the evolutionary history of a large family of
transcriptional repressors. Genome Res. 16:669–677. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cowger JJ, Zhao Q, Isovic M and Torchia J:
Biochemical characterization of the zinc-finger protein 217
transcriptional repressor complex: Identification of a ZNF217
consensus recognition sequence. Oncogene. 26:3378–3386. 2007.
View Article : Google Scholar
|
|
11
|
Qiang W, Zhao Y, Yang Q, Liu W, Guan H, Lv
S, Ji M, Shi B and Hou P: ZIC1 is a putative tumor suppressor in
thyroid cancer by modulating major signaling pathways and
transcription factor FOXO3a. J Clin Endocrinol Metab.
99:E1163–E1172. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang X, Yuan W, Huang W, Bai Y, Deng Y,
Zhu C, Liang P, Li Y, Du X, Liu M, et al: ZNF569, a novel
KRAB-containing zinc finger protein, suppresses MAPK signaling
pathway. Biochem Biophys Res Commun. 346:621–628. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang GJ, He Z and Ma L: ZFP932 suppresses
cellular Hedgehog response and Patched1 transcription. Vitam Horm.
88:309–332. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li A, Jiao Y, Yong KJ, Wang F, Gao C, Yan
B, Srivastava S, Lim GS, Tang P, Yang H, et al: SALL4 is a new
target in endometrial cancer. Oncogene. 34:63–72. 2015. View Article : Google Scholar
|
|
15
|
Tune CE, Pilon M, Saiki Y and Dosch HM:
Sustained expression of the novel EBV-induced zinc finger gene,
ZNFEB, is critical for the transition of B lymphocyte activation to
oncogenic growth transformation. J Immunol. 168:680–688. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nakaya T, Ogawa S, Manabe I, Tanaka M,
Sanada M, Sato T, Taketo MM, Nakao K, Clevers H, Fukayama M, et al:
KLF5 regulates the integrity and oncogenicity of intestinal stem
cells. Cancer Res. 74:2882–2891. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang S, Cheng Y, Du W, Lu L, Zhou L, Wang
H, Kang W, Li X, Tao Q, Sung JJ, et al: Zinc-finger protein 545 is
a novel tumour suppressor that acts by inhibiting ribosomal RNA
transcription in gastric cancer. Gut. 62:833–841. 2013. View Article : Google Scholar
|
|
18
|
Cheng Y, Liang P, Geng H, Wang Z, Li L,
Cheng SH, Ying J, Su X, Ng KM, Ng MH, et al: A novel 19q13
nucleolar zinc finger protein suppresses tumor cell growth through
inhibiting ribosome biogenesis and inducing apoptosis but is
frequently silenced in multiple carcinomas. Mol Cancer Res.
10:925–936. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiao Y, Xiang T, Luo X, Li C, Li Q, Peng
W, Li L, Li S, Wang Z, Tang L, et al: Zinc-finger protein 545
inhibits cell proliferation as a tumor suppressor through inducing
apoptosis and is disrupted by promoter methylation in breast
cancer. PLoS One. 9:e1109902014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Li J, Cui Y, Li T, Ng KM, Geng H,
Li H, Shu XS, Li H, Liu W, et al: CMTM3, located at the critical
tumor suppressor locus 16q22.1, is silenced by CpG methylation in
carcinomas and inhibits tumor cell growth through inducing
apoptosis. Cancer Res. 69:5194–5201. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
22
|
Herman JG and Baylin SB: Gene silencing in
cancer in association with promoter hypermethylation. N Engl J Med.
349:2042–2054. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Deng J, Liang H, Ying G, Dong Q, Zhang R,
Yu J, Fan D and Hao X: Poor survival is associated with the
methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter
in gastric cancer. Oncotarget. 6:4482–4495. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu J, Li X, Tao Q, Yu XL, Cheng ZG, Han
ZY, Guo M and Liang P: Hypermethylation of ZNF545 is associated
with poor prognosis in patients with early-stage hepatocellular
carcinoma after thermal ablation. Gut. 64:1836–1837. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zong D, Yin L, Zhong Q, Guo WJ, Xu JH,
Jiang N, Lin ZR, Li MZ, Han P, Xu L, et al: ZNF488 enhances the
invasion and tumorigenesis in nasopharyngeal carcinoma via the Wnt
signaling pathway involving epithelial mesenchymal transition.
Cancer Res Treat. 48:334–344. 2016. View Article : Google Scholar :
|
|
26
|
Liu G, Jiang S, Wang C, Jiang W, Liu Z,
Liu C, Saiyin H, Yang X, Shen S, Jiang D, et al: Zinc finger
transcription factor 191, directly binding to β-catenin promoter,
promotes cell proliferation of hepatocellular carcinoma.
Hepatology. 55:1830–1839. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang W, Chen X, Kato Y, Evans PM, Yuan S,
Yang J, Rychahou PG, Yang VW, He X, Evers BM, et al: Novel cross
talk of Kruppel-like factor 4 and beta-catenin regulates normal
intestinal homeostasis and tumor repression. Mol Cell Biol.
26:2055–2064. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pourebrahim R, Houtmeyers R, Ghogomu S,
Janssens S, Thelie A, Tran HT, Langenberg T, Vleminckx K,
Bellefroid E, Cassiman JJ, et al: Transcription factor Zic2
inhibits Wnt/β-catenin protein signaling. J Biol Chem.
286:37732–37740. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Doerks T, Copley RR, Schultz J, Ponting CP
and Bork P: Systematic identification of novel protein domain
families associated with nuclear functions. Genome Res. 12:47–56.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Morin PJ, Sparks AB, Korinek V, Barker N,
Clevers H, Vogelstein B and Kinzler KW: Activation of
beta-catenin-Tcf signaling in colon cancer by mutations in
beta-catenin or APC. Science. 275:1787–1790. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Datta SR, Brunet A and Greenberg ME:
Cellular survival: A play in three Akts. Genes Dev. 13:2905–2927.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qing H, Gong W, Che Y, Wang X, Peng L,
Liang Y, Wang W, Deng Q, Zhang H and Jiang B: PAK1-dependent MAPK
pathway activation is required for colorectal cancer cell
proliferation. Tumour Biol. 33:985–994. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Levidou G, Saetta AA, Gigelou F, Karlou M,
Papanastasiou P, Stamatelli A, Kavantzas N, Michalopoulos NV,
Agrogiannis G, Patsouris E, et al: ERK/pERK expression and B-raf
mutations in colon adenocarcinomas: Correlation with
clinicopathological characteristics. World J Surg Oncol. 10:472012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Khor TO, Gul YA, Ithnin H and Seow HF:
Positive correlation between overexpression of phospho-BAD with
phosphorylated Akt at serine 473 but not threonine 308 in
colorectal carcinoma. Cancer Lett. 210:139–150. 2004. View Article : Google Scholar : PubMed/NCBI
|
